Lantern Pharma Inc. (LTRN) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lantern Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.519 Good day and welcome to the NOVA Limited fourth quarter and full year 2024 00:00:05.519 -- 00:00:10.847 results conference call. All participants will be in listen-only mode. 00:00:10.847 -- 00:00:15.413 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.413 -- 00:00:17.977 key followed by zero. 00:00:17.977 -- 00:00:22.884 After today's presentation, there will be an opportunity to ask questions. 00:00:22.884 -- 00:00:27.891 To ask a question, you may press star then one on your telephone keypad. 00:00:27.891 -- 00:00:32.010 To withdraw your question, please press star, then two. 00:00:32.010 -- 00:00:35.473 Please note this event is being recorded. 00:00:35.473 -- 00:00:40.979 I would now like to turn the conference over to Mary Siegel, CEO of MSIR. 00:00:40.979 -- 00:00:43.221 Please go ahead. 00:00:43.221 -- 00:00:46.104 Thank you, operator, and good day to everybody. 00:00:46.104 -- 00:00:51.790 I would like to welcome all of you to NOVA's fourth quarter and full year 2024 00:00:51.790 -- 00:00:53.271 financial 00:00:53.271 -- 00:00:58.913 results conference call. With us on the line today are Gabby Weissman, 00:00:58.913 -- 00:01:04.179 President and CEO, and Guy Kisner, CFO. 00:01:04.179 -- 00:01:09.527 Before we begin, I would like to remind our listeners that certain information provided 00:01:09.527 -- 00:01:14.553 on this call may contain forward-looking statements, and the safe harbor 00:01:14.553 -- 00:01:19.560 statement outlined in today's earnings release also pertains 00:01:19.560 -- 00:01:24.793 to this call. If you have not received a copy of the release, Please view 00:01:24.793 -- 00:01:29.937 it in the investor relations section of the company's website. 00:01:29.93...